Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Psychedelic Drugs

Study suggests psychedelic users reframe “bad trips” into positive experiences through detailed narratives

by Beth Ellwood
July 5, 2021
in Psychedelic Drugs
Share on TwitterShare on Facebook
Stay informed on the latest psychology and neuroscience research—follow PsyPost on LinkedIn for daily updates and insights.

A study published in the International Journal of Drug Policy asked psychedelic drug users to share their experiences with drug use, and particularly, their experiences with “bad trips.” An analysis of these narratives revealed that many psychedelic users turn to storytelling to reframe challenging trips into positive experiences.

Psychedelics or hallucinogens are psychoactive substances that trigger altered states of consciousness, affecting mood, perception, and cognition. While hallucinogens are considered non-addictive and have low toxicity, they do come with a major pitfall. The drugs occasionally induce bad trips — intense negative reactions that can include anxiety, paranoia, panic attacks, and frightening hallucinations.

Interestingly, many users of psychedelics seem to embrace the positives in these challenging trips, despite describing them as intensely frightening. Researchers Liridona Gashi and her team proposed that one way psychedelic users might find meaning in such bad trips is through storytelling. Narratives might allow drug users to reframe these adverse incidents into valuable experiences — the same way that humans commonly make sense of the world by telling stories.

To explore this, the researchers conducted interviews among 50 Norwegian psychedelic users, most of whom were in their twenties or thirties. The majority of participants had used hallucinogens between 10 and 50 times and the two most common drugs cited were LSD and psilocybin. The participants were asked open-ended questions to elicit details about their experiences with bad trips, including how frightened they were, whether the experience had changed them, and how they felt the following day.

All but two participants described experiencing a bad trip. In line with previous findings, many stories included experiences of paranoia, confusion, panic attacks, and troubling visions. Gashi and her colleagues say that many subjects described particularly intense feelings of going insane or losing their sense of self. For example, some described “how seconds or minutes could be experienced as an eternity, and that they were spinning around problems they were unable to solve.”

Despite describing these highly distressing experiences, many participants seemed to look back on bad trips with gratitude, suggesting that the experiences had offered them deep insights and opened up repressed feelings. The trips were regarded as having helped them work through personal emotions or having improved their outlook on life. Even those who described having experienced a psychotic episode during a trip still saw value in these experiences.

Many subjects also alluded to the distinction between experienced and non-experienced drug users, maintaining that bad trips arise due to a drug user’s lack of competence and are no fault of the substance itself. The study authors note that some participants even blamed themselves for a bad trip, showing an unusual loyalty to the drug.

“While psychedelic experiences often have ineffable characteristics, the bad trip stories our participants told were typically rich and detailed,” Gashi and team write. “The psychedelic users were skilled story-tellers, with comprehensive vocabularies, sometimes drawing on sophisticated language from both literature and philosophy.”

The authors propose that these narratives might partly explain why bad trips can be construed as both negative and positive experiences at the same time. Like trauma narratives, storytelling might serve as a coping mechanism, helping psychedelic users process their emotions and draw meaning from negative experiences.

The study, “Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences”, was authored by Liridona Gashi, Sveinung Sandberg, and Willy Pedersen.

RELATED

Psychedelic mushrooms and quiet quitting: Psilocybin use tied to working fewer overtime hours
Depression

Psilocybin therapy linked to lasting depression remission five years later

October 27, 2025
LSD might have a small positive effect when used to treat substance use disorders
LSD

LSD might have a small positive effect when used to treat substance use disorders

October 22, 2025
Psychedelic experiences linked to reduced cannabis use and greater psychological flexibility
Addiction

Psychedelic experiences linked to reduced cannabis use and greater psychological flexibility

October 17, 2025
Futuristic digital illustration of a human brain with neural networks and bright colors, representing psychology, neuroscience, and mental health research.
Ayahuasca

Long-term ayahuasca use linked to distinct emotional brain activity and higher resilience

October 14, 2025
New study highlights psilocybin’s promise for major depressive disorder treatment
Psilocybin

Psilocybin therapy linked to reduced suicidal thoughts in people with psychiatric disorders

October 9, 2025
Scientists studied ayahuasca users—what they found about death is stunning
Ayahuasca

Scientists studied ayahuasca users—what they found about death is stunning

October 8, 2025
Psilocybin-assisted group therapy may help reduce depression and burnout among healthcare workers
Psilocybin

Psilocybin-assisted group therapy may help reduce depression and burnout among healthcare workers

October 4, 2025
Vivid digital artwork of a human brain with colorful neural pathways and energetic patterns, illustrating neuroscience, psychology, and brain activity concepts.
Psychedelic Drugs

Psychedelics may not boost creativity as widely believed, new study suggests

September 28, 2025

PsyPost Merch

STAY CONNECTED

LATEST

Shyness linked to spontaneous activity in the brain’s cerebellum

Scientists pinpoint genetic markers that signal higher Alzheimer’s risk

A particular taste may directly signal the brain to wake up

COVID-19 exposure during pregnancy may increase child’s autism risk

Life purpose linked to 28% lower risk of cognitive decline

Disgust sensitivity is linked to a sexual double standard, study finds

New review questions the evidence for common depression treatments

In shock discovery, scientists link mother’s childhood trauma to specific molecules in her breast milk

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy